Form 4 for SONM DNA X, Inc.
Accepted 2023-09-29 00:00:00 ET · period of report 2023-09-28 · accession 0001493152-23-034933 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | 2023-09-28 | SONM | Wang Jeffrey | Dir, 10% | A - Grant | $0.00 | +89.5K | 231.1K | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-28 | A | A | 89,525 | $0.00 | 231,080 | D | — | — | (F1) Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F2) Consists of (i) 79,006 shares of common stock and (ii) 152,074 unvested restricted stock units. |